Par Drugs and Chemicals Limited

NSE:PAR.NS

95.99 (INR) • At close July 4, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2025 Q42025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 275.7720187.824-366.539366.539-298.54298.54-222.43222.43-193.798193.798-162.064162.064-179.107179.107-211.638211.638132.225-73.79273.79273.79272.99772.9970.3060.3060.1520.152
Short Term Investments 000733.07831.306597.080444.8630.016387.5960324.12810.016358.2140423.27600147.58300000000
Cash and Short Term Investments 275.772187.824187.824366.539366.539298.54298.54222.43222.43193.798193.798162.064162.064179.107179.107211.638211.638132.22573.79273.79273.79272.99772.9970.3060.3060.1520.152
Net Receivables 167.1410229.8470137.1420170.7210169.6890222.3810184.6720141.3870124.514146.1450123.684123.684124.212124.21285.19785.197123.931123.931
Inventory 61.059049.344041.77041.739053.79045.308047.127029.892029.96726.105029.16834.90631.33531.33542.94248.94343.79443.794
Other Current Assets 44.638-187.82423.622095.369029.494083.956025.132033.919033.226036.80218.83709.8039.80311.84911.8497.3957.3952.3352.335
Total Current Assets 548.610490.637366.539596.236298.54540.494222.43494.37193.798486.619162.064435.639179.107383.612211.638411.855323.31273.792242.185242.185240.393240.393141.842141.84170.212170.212
Non-Current Assets:
Property, Plant & Equipment, Net 389.1490401.2770413.3490409.6520386.9450354.9330343.5140343.9260343.709340.9430351.352351.352338.338338.338363.41363.41378.084378.084
Goodwill 000000000000000000000000000
Intangible Assets 000000000000000000000000000
Goodwill and Intangible Assets 0000-0.4000-0.7000-2.80100000000000000
Long Term Investments 250.70258.64600.11900.100.100.101.60100.100.10.66500.5650.5650.5650.5650.5650.5650.5650.565
Tax Assets 00000.40000.70001.200000000000000
Other Non-Current Assets 5.44205.989-366.5396.407-298.546.304-222.437.264-193.7987.696-162.0647.749-179.1077.945-211.6388.1767.806-73.7927.057.057.8757.8747.7396.8587.6487.648
Total Non-Current Assets 645.2910665.912-366.539419.875-298.54416.056-222.43394.309-193.798362.729-162.064351.263-179.107351.971-211.638351.986349.414-73.792358.967358.967346.778346.777371.714370.833386.297386.297
Total Assets 1,193.90101,156.54901,016.1110956.550888.6790849.3480786.9020735.5830763.841672.7260601.152601.152587.171587.17513.555512.673556.509556.509
Liabilities & Equity:
Current Liabilities:
Account Payables 108.9140107.589053.5620100.746080.915078.9990106.618057.858067.17871.173062.04562.04569.55169.55149.31849.31872.90272.902
Short Term Debt 000000000036.1820000039.2940013.92513.9250055.49655.49476.76876.768
Tax Payables 000049.7560000000000000000000000
Deferred Revenue 00000.0510000.623020.24400.0900046.5280029.98200016.468000
Other Current Liabilities 56.771045.951021.022032.239058.979035.145041.956031.629053.3261.247032.47132.47126.89226.89219.74219.74420.65120.651
Total Current Liabilities 165.6850153.540124.3910132.9850139.8940150.3260148.574089.4870159.792132.420108.442108.44296.44396.443124.556124.557170.321170.321
Non-Current Liabilities:
Long Term Debt 0000000000000039.619043.91743.335046.19146.19161.03961.03960.31360.314127.661127.661
Deferred Revenue Non-Current 000000000000000003.8620003.26903.269000
Deferred Tax Liabilities Non-Current 0035.4035.4035035035.5035.5034.051034.05135.854036.512035.075034.243000
Other Non-Current Liabilities 38.467-967.6090-856.32002.58801.40204.5604.05603.525037.9860.001040.37440.3740.00238.34434.24437.51337.86437.864
Total Non-Current Liabilities 38.467-967.60935.4-856.3235.4037.588036.402040.06039.556077.195081.90383.052086.56586.56599.38599.38397.82697.827165.525165.525
Total Liabilities 204.152-967.609188.94-856.32159.7910170.5730176.2960190.3860188.130166.6820241.695215.4720195.007195.007195.828195.826222.382222.383335.846335.846
Equity:
Preferred Stock 000000000000000000000000057.557.5
Common Stock 123.0460123.0460123.0460123.0460123.0460123.0460123.0460123.046061.52361.523061.52361.52361.52361.52344.80344.8032727
Retained Earnings 0000625.512000481.575000367.964000291.33700175.337175.68700145.637145.103135.477135.477
Accumulated Other Comprehensive Income/Loss 866.703967.6090856.32733.274785.977662.931712.3831.036658.963535.917598.7721.036568.901445.855522.1450.686395.732406.1450.6860.686329.821329.8210.6860.6860.6860.686
Other Total Stockholders Equity 00844.5630106.726000106.7260-0.0010106.726000168.249-0.0010168.249168.249-0.0010100.5899.69700
Total Shareholders Equity 989.749967.609967.609856.32856.32785.977785.977712.383712.383658.963658.962598.772598.772568.901568.901522.145522.145457.254406.145406.145406.145391.343391.344291.173290.289220.663220.663
Total Equity 989.749967.609967.609856.32856.32785.977785.977712.383712.383658.963658.962598.772598.772568.901568.901522.145522.145457.254406.145406.145406.145391.343391.344291.173290.289220.663220.663
Total Liabilities & Shareholders Equity 1,193.90101,156.549856.321,016.111785.977956.55712.383888.679658.963849.348598.772786.902568.901735.583522.145763.841672.726406.145601.152601.152587.171587.17513.555512.673556.509556.509